Dr. Weissmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 mount auburn street
Wyman 3
Cambridge, MA 02138Phone+1 617-497-9646
Summary
- Dr. Lisa Weissmann is an oncologist in Cambridge, MA and is affiliated with multiple hospitals in the area, including Mount Auburn Hospital, Cambridge Health Alliance, and Beth Israel Deaconess Medical Center. She received her medical degree from NYU School of Medicine and has been in practice 36 years. She specializes in hematologic oncology and is experienced in breast cancer, hereditary breast/ovarian cancer, familial breast/ovarian cancer, branchiogenic carcinoma, and tubular carcinoma of the breast.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1985 - 1989
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1985
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1981 - 1984
- New York University School of MedicineClass of 1981
Certifications & Licensure
- MA State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09
Publications & Presentations
PubMed
- 1211 citationsClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20 - 20 citationsA Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.Maheen Z. Abidi, David M. Aboulafia, Melissa K. Accordino, Jared D. Acoba, Manmeet Ahluwalia
Cancer Cell. 2020-12-14 - 48 citationsAdherence to oral chemotherapy: Challenges and opportunities.Susan A. Krikorian, Susan E. Pories, Gary Tataronis, Thomas Caughey, Kirsten Chervinsky
Journal of Oncology Pharmacy Practice. 2019-10-01
Press Mentions
- Hormonal TherapyFebruary 14th, 2017
- ChemotherapyFebruary 14th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: